President Trump announces major pharmaceutical companies will lower prescription drug prices in the U.S., matching prices in other developed countries for Medicaid patients. This includes new medications at a most-favored-nation price. The move aims to address high drug costs, impacting those without coverage or high out-of-pocket expenses. Medicaid patients may see reduced co-payments, benefiting state budgets. A new platform, TrumpRx, will launch in January for direct drug purchases. Companies will also donate supplies to a national reserve, ensuring availability of critical medications during emergencies.
DNN | The Daily News Now!
The world’s first global local news network.
Every city. Every story. AI powered.
Hosted on Acast. See acast.com/privacy for more information.
Published on 1 day, 8 hours ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate